Literature DB >> 24372967

Late acute rejection: incidence, risk factors, and effect on graft survival and function.

Loai Eid1, Shamir Tuchman, Asha Moudgil.   

Abstract

Long-term graft survival and function has not kept pace with short-term success in kidney transplant (Tx) recipients. LAR ≥6 months post-Tx may contribute to lack of improvement; risk factors for LAR are not well known. Of 64 Tx recipients followed over six yr, 23 (35.9%) had LAR (LAR group) and 41 had no LAR (no LAR group). Of all variables, significant risk factors for LAR included DGF, (43.4% LAR vs. 14.6% in no LAR group, p = 0.0096); de novo DSA (65.2% vs. 26.8%, p = 0.003); mean COV% of TAC (41.8% vs. 34.6%, p = 0.03); and non-adherence (34.8% vs. 7.3%, p = 0.0043). DGF and DSA remained statistically significant (p = 0.002 and 0.003, respectively); COV% TAC had borderline significance (p = 0.057), and non-adherence was not significant on multivariate regression analysis. Patients with LAR had inferior graft survival and function, whereas graft function was stable in the no LAR group over a mean follow-up of 31.2 months. Patients with de novo DSA and DGF should be considered at risk of LAR; an early diagnosis and treatment of LAR may improve graft survival and function.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  delayed graft function; donor-specific antibodies; kidney transplantation; non-adherence; pediatric; tacrolimus

Mesh:

Substances:

Year:  2013        PMID: 24372967     DOI: 10.1111/petr.12203

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  6 in total

1.  Gene Expression in Biopsies of Acute Rejection and Interstitial Fibrosis/Tubular Atrophy Reveals Highly Shared Mechanisms That Correlate With Worse Long-Term Outcomes.

Authors:  B D Modena; S M Kurian; L W Gaber; J Waalen; A I Su; T Gelbart; T S Mondala; S R Head; S Papp; R Heilman; J J Friedewald; S M Flechner; C L Marsh; R S Sung; H Shidban; L Chan; M M Abecassis; D R Salomon
Journal:  Am J Transplant       Date:  2016-03-15       Impact factor: 8.086

Review 2.  Induction therapy of basiliximab versus antithymocyte globulin in renal allograft: a systematic review and meta-analysis.

Authors:  Kun Wang; Xianlin Xu; Min Fan
Journal:  Clin Exp Nephrol       Date:  2017-10-06       Impact factor: 2.801

3.  Defining a threshold for tacrolimus intra-patient variability associated with late acute cellular rejection in paediatric kidney transplant recipients.

Authors:  Karmila Abu Bakar; Nor Asiah Mohamad; Zsolt Hodi; Tom McCulloch; Alun Williams; Martin Christian; Tim Key; Jon Jin Kim
Journal:  Pediatr Nephrol       Date:  2019-09-13       Impact factor: 3.714

4.  Predicting acute rejection in children, adolescents, and young adults with a kidney transplant by assessing barriers to taking medication.

Authors:  Charles D Varnell; Kristin L Rich; Bin Zhang; Adam C Carle; Ahna L H Pai; Avani C Modi; David K Hooper
Journal:  Pediatr Nephrol       Date:  2021-01-27       Impact factor: 3.651

5.  Nomograms for Predicting the Incidence of Late-Onset Acute Cellular Rejection in Patients After Pediatric Liver Transplantation.

Authors:  Zhuyuan Si; Chong Dong; Chao Sun; Kai Wang; Wei Zhang; Weiping Zheng; Xinzhe Wei; Wei Gao; Zhongyang Shen
Journal:  Front Pediatr       Date:  2022-06-03       Impact factor: 3.569

6.  Circulating de novo Donor Specific Antibodies and Carotid Intima-media Thickness in Pediatric Kidney Transplant Recipients, A Pilot Study.

Authors:  Kristen Sgambat; Sarah Clauss; Asha Moudgil
Journal:  Front Pediatr       Date:  2020-01-31       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.